Marko Nicholas F, Frank Bryan, Quackenbush John, Lee Norman H
The George Washington University Medical Center, USA.
BMC Genomics. 2005 Mar 1;6:27. doi: 10.1186/1471-2164-6-27.
Small quantities of RNA (1-4 microg total RNA) available from biological samples frequently require a single round of amplification prior to analysis, but current amplification strategies have limitations that may restrict their usefulness in downstream genomic applications. The Eberwine amplification method has been extensively validated but is limited by its ability to produce only antisense RNA. Alternatives lack extensive validation and are often confounded by problems with bias or yield attributable to their greater biological and technical complexity.
To overcome these limitations, we have developed a straightforward and robust protocol for amplification of RNA in the sense orientation. This protocol is based upon Eberwine's method but incorporates elements of more recent amplification techniques while avoiding their complexities. Our technique yields greater than 100-fold amplification, generates long transcript, and produces mRNA that is well suited for use with microarray applications. Microarrays performed with RNA amplified using this protocol demonstrate minimal amplification bias and high reproducibility.
The protocol we describe here is readily adaptable for the production of sense or antisense, labeled or unlabeled RNA from intact or partially-degraded prokaryotic or eukaryotic total RNA. The method outperforms several commercial RNA amplification kits and can be used in conjunction with a variety of microarray platforms, such as cDNA arrays, oligonucleotide arrays, and Affymetrix GeneChip arrays.
从生物样品中获得的少量RNA(总RNA 1 - 4微克)在分析前通常需要进行一轮扩增,但目前的扩增策略存在局限性,可能会限制其在下游基因组应用中的效用。埃伯温扩增方法已得到广泛验证,但仅限于产生反义RNA。其他方法缺乏广泛验证,并且由于其更大的生物学和技术复杂性,往往存在偏差或产量问题。
为克服这些局限性,我们开发了一种简单且稳健的正义链RNA扩增方案。该方案基于埃伯温方法,但融入了最新扩增技术的元素,同时避免了其复杂性。我们的技术实现了超过100倍的扩增,产生长转录本,并生成非常适合微阵列应用的mRNA。使用该方案扩增的RNA进行的微阵列显示出最小的扩增偏差和高重现性。
我们在此描述的方案易于适用于从完整或部分降解的原核或真核总RNA生产正义链或反义链、标记或未标记的RNA。该方法优于几种商业RNA扩增试剂盒,可与多种微阵列平台结合使用,如cDNA阵列、寡核苷酸阵列和Affymetrix基因芯片阵列。